Analysts Set Healthcare Realty Trust Incorporated (NYSE:HR) PT at $18.88

Shares of Healthcare Realty Trust Incorporated (NYSE:HR) have been assigned a consensus recommendation of “Hold” from the ten analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, six have given a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $18.8750.

A number of analysts have recently commented on the company. Wall Street Zen raised Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Weiss Ratings reiterated a “hold (c)” rating on shares of Healthcare Realty Trust in a research note on Monday, December 29th. Citigroup boosted their target price on Healthcare Realty Trust from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, November 12th. Cantor Fitzgerald raised their price target on Healthcare Realty Trust from $19.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, February 17th. Finally, Wells Fargo & Company lifted their price target on Healthcare Realty Trust from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th.

Healthcare Realty Trust Trading Down 0.6%

Shares of HR stock opened at $18.45 on Friday. The company’s fifty day moving average price is $17.28 and its 200-day moving average price is $17.60. The stock has a market cap of $6.44 billion, a PE ratio of -25.98 and a beta of 0.96. Healthcare Realty Trust has a 12 month low of $14.09 and a 12 month high of $18.97.

Healthcare Realty Trust (NYSE:HR) last issued its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.36). The business had revenue of $282.69 million for the quarter, compared to analysts’ expectations of $284.37 million. Healthcare Realty Trust had a negative net margin of 20.84% and a negative return on equity of 5.07%. The company’s revenue was down 7.6% on a year-over-year basis. During the same period last year, the business earned $0.40 earnings per share. Healthcare Realty Trust has set its FY 2026 guidance at 1.580-1.640 EPS. On average, sell-side analysts forecast that Healthcare Realty Trust will post 1.59 earnings per share for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 11th. Shareholders of record on Tuesday, February 24th will be issued a $0.24 dividend. The ex-dividend date of this dividend is Tuesday, February 24th. This represents a $0.96 annualized dividend and a yield of 5.2%. Healthcare Realty Trust’s payout ratio is -135.21%.

Institutional Investors Weigh In On Healthcare Realty Trust

Several institutional investors and hedge funds have recently made changes to their positions in the company. US Bancorp DE grew its holdings in shares of Healthcare Realty Trust by 5.8% in the third quarter. US Bancorp DE now owns 10,959 shares of the real estate investment trust’s stock worth $198,000 after acquiring an additional 602 shares during the period. Consolidated Portfolio Review Corp boosted its position in Healthcare Realty Trust by 1.2% in the third quarter. Consolidated Portfolio Review Corp now owns 55,786 shares of the real estate investment trust’s stock worth $1,006,000 after purchasing an additional 637 shares during the last quarter. Linden Thomas Advisory Services LLC grew its stake in shares of Healthcare Realty Trust by 2.7% during the 3rd quarter. Linden Thomas Advisory Services LLC now owns 31,445 shares of the real estate investment trust’s stock valued at $567,000 after purchasing an additional 826 shares during the period. Geneos Wealth Management Inc. grew its stake in shares of Healthcare Realty Trust by 4.2% during the 4th quarter. Geneos Wealth Management Inc. now owns 25,337 shares of the real estate investment trust’s stock valued at $429,000 after purchasing an additional 1,012 shares during the period. Finally, Smartleaf Asset Management LLC increased its position in shares of Healthcare Realty Trust by 179.7% during the 3rd quarter. Smartleaf Asset Management LLC now owns 1,608 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 1,033 shares during the last quarter.

About Healthcare Realty Trust

Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.

The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.